Efficacy of IRC ablation of anal HSIL following observation in HIV-infected participants: AIDS Malignancy Trial 076
Background: Anal HSIL ablation may reduce the incidence of invasive cancer, but few data exist on treatment efficacy in patients with delayed treatment after observation. Methods: A multisite clinical trial of HIV-positive participants (≥27 years old) with 1–3 biopsy-proven anal HSIL randomized to I...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-06-01
|
| Series: | Papillomavirus Research |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405852118300582 |